Zai Lab Announces Upcoming Presentations in February Investor Conferences

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB) announced participation in two upcoming virtual investor conferences in February 2021. The Guggenheim Healthcare Talks 2021 Oncology Day fireside chat is scheduled for February 11 at 12:00 p.m. ET, and the 2021 SVB Leerink Global Healthcare Conference presentation will occur on February 26 at 8:00 a.m. ET. A live webcast of the latter will be accessible under the 'Events & Presentations' section of Zai Lab's website, with an archived replay available for 90 days post-event. Zai Lab focuses on innovative treatments for significant medical needs globally.

SHANGHAI and SAN FRANCISCO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that senior management from Zai Lab will be presenting in the following upcoming virtual investor conferences in February. Details are as follows:

Guggenheim Healthcare Talks 2021 Oncology Day
Fireside chat: Thursday, February 11, 2021 at 12:00 p.m. ET

2021 SVB Leerink Global Healthcare Conference
Presentation: Friday, February 26, 2021 at 8:00 a.m. ET

A live webcast of the 2021 SVB Leerink Global Healthcare Conference presentation will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 90 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative commercial-stage biopharmaceutical company focused on bringing transformative medicines for cancer and infectious and autoimmune diseases to patients in China and around the world. We aim to address significant unmet medical needs in large, fast-growing segments of the pharmaceutical market. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and drug candidates. We have also built an in-house team with strong drug discovery and translational research capabilities and are establishing a pipeline of proprietary drug candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com

Zai Lab Limited

Source: Zai Lab Limited

FAQ

What are the dates for Zai Lab's upcoming investor conferences in February 2021?

Zai Lab will participate in the Guggenheim Healthcare Talks on February 11 and the SVB Leerink Global Healthcare Conference on February 26, 2021.

What time is Zai Lab's presentation at the SVB Leerink Global Healthcare Conference?

Zai Lab's presentation at the SVB Leerink Global Healthcare Conference is scheduled for February 26, 2021, at 8:00 a.m. ET.

Where can I find the live webcast of Zai Lab's upcoming conference presentation?

The live webcast of Zai Lab's presentation will be available under the 'Events & Presentations' section of their website.

How long will the archived replay of Zai Lab's presentation be available?

The archived replay of Zai Lab's presentation will be accessible for 90 days following the event.

What is the focus of Zai Lab as a biopharmaceutical company?

Zai Lab is focused on developing innovative medicines for cancer, infectious, and autoimmune diseases, addressing significant unmet medical needs.